R. Bulaya-Tembo

Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019–September 2020

Marg Sloan, T. Al-Samarrai, D. Onotu, 2022, MMWR. Morbidity and mortality weekly report.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

D. Pillay, J. Kigozi, E. Katabira, 2014, The Journal of antimicrobial chemotherapy.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.